Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Webster

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Pain Medicine (Malden, Mass.)|June 11, 2013
Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid usersBeatrice Setnik, Kenneth Sommerville, Veeraindar Goli, et al.
Journal of Managed Care Pharmacy : JMCP|May 4, 2010
Review of regulatory programs and new opioid technologies in chronic pain management: balancing the risk of medication abuse with medical needDavid Fishbain, Sandra Johnson, Lynn Webster, et al.
Journal of Opioid Management|May 28, 2013
A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patientsBeatrice Setnik, Carl L Roland, Veeraindar Goli, et al.
Journal of Pain Research|July 23, 2021
Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 StudiesMichael Camilleri, Martin Hale, Bart Morlion, et al.
Pain|June 4, 2013
A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipationLynn Webster, Sunita Dhar, Michael Eldon, et al.
Pain|March 11, 2024
The effects of virtual reality neuroscience-based therapy on clinical and neuroimaging outcomes in patients with chronic back pain: a randomized clinical trialMarta Čeko, Tassilo Baeuerle, Lynn Webster, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
The Effects of Virtual Reality Neuroscience-based Therapy on Clinical and Neuroimaging Outcomes in Patients with Chronic Back Pain: A Randomized Clinical TrialMarta Čeko, Tassilo Baeuerle, Lynn Webster, et al.
Postgraduate Medicine|August 21, 2014
Comparison of subjective effects of extended-release versus immediate-release oxycodone/acetaminophen tablets in healthy nondependent recreational users of prescription opioids: a randomized trialTerri Morton, Kenneth Kostenbader, Jeannie Montgomery, et al.
Pain Medicine (Malden, Mass.)|February 27, 2016
Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal BuprenorphineLynn Webster, Daniel Gruener, Todd Kirby, et al.
Sleep & Breathing = Schlaf & Atmung|August 7, 2008
Hypoxemia in patients on chronic opiate therapy with and without sleep apneaMohammed Mogri, Himanshu Desai, Lynn Webster, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Pain Medicine (Malden, Mass.)|June 11, 2013
Assessment of pharmacodynamic effects following oral administration of crushed morphine sulfate and naltrexone hydrochloride extended-release capsules compared with crushed morphine sulfate controlled-release tablets and placebo in nondependent recreational opioid usersBeatrice Setnik, Kenneth Sommerville, Veeraindar Goli, et al.
Journal of Managed Care Pharmacy : JMCP|May 4, 2010
Review of regulatory programs and new opioid technologies in chronic pain management: balancing the risk of medication abuse with medical needDavid Fishbain, Sandra Johnson, Lynn Webster, et al.
Journal of Opioid Management|May 28, 2013
A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patientsBeatrice Setnik, Carl L Roland, Veeraindar Goli, et al.
Journal of Pain Research|July 23, 2021
Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 StudiesMichael Camilleri, Martin Hale, Bart Morlion, et al.
Pain|June 4, 2013
A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipationLynn Webster, Sunita Dhar, Michael Eldon, et al.
Pain|March 11, 2024
The effects of virtual reality neuroscience-based therapy on clinical and neuroimaging outcomes in patients with chronic back pain: a randomized clinical trialMarta Čeko, Tassilo Baeuerle, Lynn Webster, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2023
The Effects of Virtual Reality Neuroscience-based Therapy on Clinical and Neuroimaging Outcomes in Patients with Chronic Back Pain: A Randomized Clinical TrialMarta Čeko, Tassilo Baeuerle, Lynn Webster, et al.
Postgraduate Medicine|August 21, 2014
Comparison of subjective effects of extended-release versus immediate-release oxycodone/acetaminophen tablets in healthy nondependent recreational users of prescription opioids: a randomized trialTerri Morton, Kenneth Kostenbader, Jeannie Montgomery, et al.
Pain Medicine (Malden, Mass.)|February 27, 2016
Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal BuprenorphineLynn Webster, Daniel Gruener, Todd Kirby, et al.
Sleep & Breathing = Schlaf & Atmung|August 7, 2008
Hypoxemia in patients on chronic opiate therapy with and without sleep apneaMohammed Mogri, Himanshu Desai, Lynn Webster, et al.
Pageof 8